Results
1 -
10 of
33Advances in HSP27 and HSP90-targeting strategies for glioblastoma, Journal of Neuro-Oncology The heat shock protein 90 inhibitor SNX5422 has a synergistic activity with histone deacetylase inhibitors in induction of death of anaplastic thyroid carcinoma cells, Endocrine HSP90 Inhibition as an Anticancer Strategy: Novel Approaches and Future Directions, Therapeutic Resistance to Anti-Hormonal Drugs in Breast Cancer Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening, Fragment-Based Drug Discovery and X-Ray Crystallography Resistance to crizotinib and therapeutic options, Guide to Targeted Therapies: Treatment Resistance in Lung Cancer HSP90 Inhibitor-Based Strategies for Cancer Therapy: Advancing Toward Clinical Impact, Heat Shock Protein-Based Therapies Hsp90 as a Potential Therapeutic Target in Retinal Disease, Retinal Degenerative Diseases Radiosensitizing effect of the novel Hsp90 inhibitor NVP-AUY922 in human tumour cell lines silenced for Hsp90??, Strahlentherapie und Onkologie